Company Data

Passage Bio Inc.

Ticker
PASG
Current Price
$0.5315 -3.36%
Market Cap
$32.8M
Price Target
Refer to Report
Volume
43.7K
52wk Range
$0.451 - $1.79
Advanced Market Data

Overview

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy